Oct4, a gene, thought to be inactive in adults, may actually play a vital role in preventing heart attacks and strokes and could also delay some of the effects of ageing, scientists have found. They said the gene could also prove critical in the field of regenerative medicine.
Representative photo.
Dr. Judith Campisi, a professor at the Buck Institute for Research on Aging, focuses her lecture on senescent cells and their role in cancer and aging. She explains how cancer is an age-related disease by describing the many conditions beyond DNA mutations that must generally be met for a malignant tumor to form. Dr. Campisi acknowledges that while cellular senescence is a powerful anti-cancer mechanism and while senescent cells may even play a key role in wound healing, senescent cells can nonetheless cause inflammation in their local environment and actually support the formation of tumors.
Visit www.sens.org/videos to view the rest of our course lecture videos.
Crowd funding interventions against aging, an update from lifespan.io
New updates from the MMTP Campaign: a mini-interview with Dr. Joao Pedro de Magalhaes of Liverpool University where he discusses the importance of animal studies, and the release of a short version of the MMTP study proposal to provide more details on the planned experiments. For more information check out the “Updates” tab on the campaign here: https://www.lifespan.io/campaigns/the-major-mouse-testing-program/ #CrowdfundTheCure #LifespanIO
CHARLOTTESVILLE, Va., May 17, 2016 — A gene that scientific dogma insists is inactive in adults actually plays a vital role in preventing the underlying cause of most heart attacks and strokes, researchers at the University of Virginia School of Medicine have determined. The discovery opens a new avenue for battling those deadly conditions, and it raises the tantalizing prospect that doctors could use the gene to prevent or delay at least some of the effects of aging.
“Finding a way to augment the expression of this gene in adult cells may have profound implications for promoting health and possibly reversing some of the detrimental effects with aging,” said researcher Gary K. Owens, PhD, director of UVA’s Robert M. Berne Cardiovascular Research Center.
Unexpected Protective Effect
New MMTP Interview on Fightaging! discussing longevity, advocacy and the urgent need to support research!
By way of following on from today’s AMA over at /r/futurology, I recently had the chance to ask a few questions of the Major Mouse Testing Program (MMTP) volunteers, a mix of scientists and advocates who aim to do their part to speed up progress towards effective treatments for the causes of aging. The group formed six months ago or so, and are presently seeking funds for their first mouse studies through crowdfunding with the Lifespan.io organization. The initial focus is on senolytic treatments capable of removing senescent cells from old tissues. I encourage you all to take a look at the details of their research proposal.
Growth in the number of dysfunctional, senescent cells is a contributing cause of degenerative aging, involved in the progression and pathology of all of the common age-related diseases. A growing body of evidence supports the outright removal approach as a way to minimize or eliminate this portion of the aging process. Unfortunately there is — as ever in the aging research field — a paucity of funding and always the need for more and better animal data in order to pull in other players with deep pockets. At this stage in the progression from laboratory to clinic, prior to the involvement of any large institutions or companies, all such efforts are important work. I’m pleased to have been able to contribute to this Major Mouse Testing Program fundraiser, and hope to see great things from this group in the future.
Continue reading “An Interview with the Advocates of the Major Mouse Testing Program Team” »
On Reddit Futurology today!
The Major Mouse Testing Program is an ambitious project of the International Longevity Alliance, featuring an international team of scientists and advocates testing therapies against aging decline. This experiment is is lead by world class stem cell researcher Dr Alexandra Stolzing and was inspired by our scientific advisor and colleague Dr Aubrey De Grey.
The Major Mouse Testing Program is seeking to speed up scientific progress in the field of regenerative medicine and bio-gerontology. After ILA experts conducted an analysis of delays preventing the development of life extension technologies, it was shown that a serious problem was the lack of robust animal data for the potential of different compounds to promote health and extend maximum lifespan. Without this data promising interventions cannot enter clinical trials and become available to the general public.
Continue reading “MMTP AMA Senolytics: Seek and Destroy! • /r/Futurology” »
Fox 29 — Good Day Philadelphia
http://www.fox29.com/140735577-video
NBC TV 10
Continue reading “Bringing The Dead Back To Life — Reanima Project / Bioquark Inc. Media Coverage” »
Check out LEAF President Keith Comito explain the origin of Lifespan.io and why crowdfunding research to extend healthy lifespan is both important and exciting.
Our current campaign is here: https://www.lifespan.io/campaigns/the-major-mouse-testing-program/ and there will be more to follow soon! Connect with us on social media and subcribe on YouTube to stay informed. #CrowdfundTheCure #LifespanIO
Continue reading “Crowdfunding the Cure for Aging | Life Extension Research, LifespanIO, and You” »
